Hypermethylation of RASSF1Ain Human and Rhesus Placentas

Autor: Chiu, Rossa W.K., Chim, Stephen S.C., Wong, Ivy H.N., Wong, Cesar S.C., Lee, Wing-Shan, To, Ka F., Tong, Joanna H.M., Yuen, Ryan K.C., Shum, Alisa S.W., Chan, John K.C., Chan, Lisa Y.S., Yuen, Jessie W.F., Tong, Yu K., Weier, Jingly F., Ferlatte, Christy, Leung, Tse N., Lau, Tze K., Lo, Kwok W., Lo, Y.M. Dennis
Zdroj: American Journal of Pathology; March 2007, Vol. 170 Issue: 3 p941-950, 10p
Abstrakt: The pseudomalignant nature of the placenta prompted us to search for tumor suppressor gene hypermethylation, a phenomenon widely reported in cancer, in the human placenta. Nine tumor suppressor genes were studied. Hypermethylation of the Ras association domain family 1 A (RASSF1A) gene was found in human placentas from all three trimesters of pregnancy but was absent in other fetal tissues. Hypermethylation of Rassf1was similarly observed in placentas from the rhesus monkey but not the mouse. An inverse relationship between RASSF1Apromoter methylation and gene expression was demonstrated by bisulfite sequencing of microdissected placental cells and immunohistochemical staining of placental tissue sections using an anti-RASSF1A antibody. Treatment of choriocarcinoma cell lines, JAR and JEG3, by 5-aza-2′-deoxycytidine and trichostatin A led to reduction in RASSF1Amethylation but increased expression. These observations extend the analogy between the primate placenta and malignant tumors to the epigenetic level.
Databáze: Supplemental Index